Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitsuko Masutani

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Cancer Science|March 8, 2013
Artemis-dependent DNA double-strand break formation at stalled replication forksJunya Unno, Masatoshi Takagi, Jinhua Piao, et al.
Current Issues in Molecular Biology|January 22, 2024
Effect of Functional Inhibition of BACE1 on Sensitization to γ-Irradiation in Cancer CellsKeitaro Nakamoto, Sota Kikuhara, Hiroaki Fujimori, et al.
The Journal of Biological Chemistry|March 29, 2013
The Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugsYuko Atsumi, Aki Inase, Tomoyuki Osawa, et al.
Biochemical Pharmacology|July 22, 2019
Development of renal failure in PargParp-1 null and Timm23 hypomorphic miceLichao Chen, Akemi Gunji, Akiko Uemura, et al.
The EMBO Journal|February 25, 2006
Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cellsHelfrid Hochegger, Donniphat Dejsuphong, Toru Fukushima, et al.
Discover Oncology|January 15, 2026
Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitorNoritaka Honda, Hirokazu Taniguchi, Sawana Ono, et al.
Cancers|April 30, 2020
Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under <i>Parg</i> DeficiencyYuki Sonoda, Yuka Sasaki, Akemi Gunji, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|December 12, 2017
Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy systemSatoshi Nakamura, Shoji Imamichi, Kazuyoshi Masumoto, et al.
Biology|March 26, 2022
Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture TherapyShoji Imamichi, Lichao Chen, Tasuku Ito, et al.
Biology|August 26, 2023
Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. <i>Biology</i> 2022, <i>11</i>, 420Shoji Imamichi, Lichao Chen, Tasuku Ito, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Cancer Science|March 8, 2013
Artemis-dependent DNA double-strand break formation at stalled replication forksJunya Unno, Masatoshi Takagi, Jinhua Piao, et al.
Current Issues in Molecular Biology|January 22, 2024
Effect of Functional Inhibition of BACE1 on Sensitization to γ-Irradiation in Cancer CellsKeitaro Nakamoto, Sota Kikuhara, Hiroaki Fujimori, et al.
The Journal of Biological Chemistry|March 29, 2013
The Arf/p53 protein module, which induces apoptosis, down-regulates histone H2AX to allow normal cells to survive in the presence of anti-cancer drugsYuko Atsumi, Aki Inase, Tomoyuki Osawa, et al.
Biochemical Pharmacology|July 22, 2019
Development of renal failure in PargParp-1 null and Timm23 hypomorphic miceLichao Chen, Akemi Gunji, Akiko Uemura, et al.
The EMBO Journal|February 25, 2006
Parp-1 protects homologous recombination from interference by Ku and Ligase IV in vertebrate cellsHelfrid Hochegger, Donniphat Dejsuphong, Toru Fukushima, et al.
Discover Oncology|January 15, 2026
Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitorNoritaka Honda, Hirokazu Taniguchi, Sawana Ono, et al.
Cancers|April 30, 2020
Reduced Tumorigenicity of Mouse ES Cells and the Augmented Anti-Tumor Therapeutic Effects under <i>Parg</i> DeficiencyYuki Sonoda, Yuka Sasaki, Akemi Gunji, et al.
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences|December 12, 2017
Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy systemSatoshi Nakamura, Shoji Imamichi, Kazuyoshi Masumoto, et al.
Biology|March 26, 2022
Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture TherapyShoji Imamichi, Lichao Chen, Tasuku Ito, et al.
Biology|August 26, 2023
Correction: Imamichi et al. Extracellular Release of HMGB1 as an Early Potential Biomarker for the Therapeutic Response in a Xenograft Model of Boron Neutron Capture Therapy. <i>Biology</i> 2022, <i>11</i>, 420Shoji Imamichi, Lichao Chen, Tasuku Ito, et al.
Pageof 10